Trending
- FDA Advisory Committee Backs RP1/Nivolumab for Advanced Melanoma
- CAR T-Cell Therapy Could Soon Expand Into Non-Oncology Indications
- TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions
- Capricor’s data clash with the FDA| STAT
- Cevostamab Shows Durable Responses in Relapsed/Refractory Multiple Myeloma
- How KRAS-Targeted Therapy May Advance Toward Cancer Prevention
- Tanning Is Getting Hot Again. Here’s What It Really Does to Your Skin
- Nogapendekin Alfa Combo Earns UAE Marketing Authorization in NMIBC, NSCLC
Thursday, July 30